Epigenos Biosciences
PrivateLast Round
Debt
Jun 3, 2022
Total Funding Raised
$901,236
Company Overview
Epigenos Biosciences operates in Healthcare & Life Sciences and is based in Morrisville, North Carolina. Its latest recorded funding round was a Debt round in June 2022.
Epigenos Biosciences is a biotechnology company that develops personalized epigenome-based therapeutics using Cas9 technology to treat diseases at the root of gene misregulation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Epigenos Biosciences Comparables
Compare Epigenos Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Moonwalk Biosciences | 85% | |
| Tune Therapeutics | 83% | |
| Epicrispr Biotechnologies | 81% |
For institutional investors. Book with your work email.
Epigenos Biosciences Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Epigenos Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KickStart Venture Services | Grant |
| NIH RADx | Grant |
| North Carolina Biotechnology Center | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 3, 2022
$250K round from North Carolina Biotechnology Center.
For institutional investors. Book with your work email.
Epigenos Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Epigenos Biosciences's valuation, stock price, and market status.
Is Epigenos Biosciences a public or private company?
Epigenos Biosciences is a private company.
What is the current stock price of Epigenos Biosciences?
Epigenos Biosciences is a private company, so its shares have no public market price. Caplight tracks Epigenos Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Epigenos Biosciences worth (valuation)?
Valuation information for Epigenos Biosciences is not publicly available.
Can I buy Epigenos Biosciences stock?
Epigenos Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Epigenos Biosciences's last funding round?
Epigenos Biosciences's most recent funding round was Debt on June 3, 2022.
Who are the main investors in Epigenos Biosciences?
Key investors in Epigenos Biosciences include KickStart Venture Services, NIH RADx, North Carolina Biotechnology Center.
Will Epigenos Biosciences IPO soon?
No public IPO plans have been announced for Epigenos Biosciences.
How can I track Epigenos Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Epigenos Biosciences's shares on secondary markets.